Exobiosphere
Exobiosphere44
About
What does Exobiosphere do?
Exobiosphere is a Luxembourg-based biotechnology company that is pioneering high-throughput drug discovery in microgravity. They are building the Orbital High-Throughput Screener (OHTS), an autonomous, standardized lab automation platform designed for space, enabling pharmaceutical and biotech partners to run automated experiments in orbit at scale. The company aims to accelerate drug discovery and unlock therapies that are difficult or impossible to develop on Earth by leveraging the unique con…
What is Exobiosphere's revenue?
StartupHub estimates Exobiosphere's annual revenue at $3.7M (range $2.1M to $9.7M, 68% confidence), based on comparable companies in the sector.
What is Exobiosphere's valuation?
StartupHub estimates Exobiosphere's effective valuation at $8.4M (range $5.4M to $13.0M, 19% confidence), based on comparable companies in the sector.
How much funding has Exobiosphere raised?
Exobiosphere has raised a total of $2M in funding. The most recent round on record is Seed.
Where is Exobiosphere headquartered?
Exobiosphere is headquartered in Esch-sur-Alzette, Luxembourg.
When was Exobiosphere founded?
Exobiosphere was founded in 2024.
What industry does Exobiosphere operate in?
Exobiosphere operates in Biotechnology, Space, Biotech, SpaceTech, Drug Discovery, Microgravity Biotechnology.
How many employees does Exobiosphere have?
Exobiosphere has approximately 27 people on record.
No comments yet. Be the first to share your take.